Validive (clonidine MBT) / Valerio Therap, Monopar Therap 
Welcome,         Profile    Billing    Logout  

2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Validive (clonidine MBT) / Monopar Therap
2021-000999-11: Study comparing the efficacy and safety of a clonidine tablet that sticks to the gum to a placebo tablet to prevent severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Estudio que compara la eficacia y la seguridad de una tableta de clonidina que se pega a la encía versus tableta de placebo para prevenir una inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta

Not yet recruiting
2/3
260
Europe
Validive (Clonidine HCl mucoadhesive buccal tablet (MBT)), Muco-adhesive buccal tablet
Monopar Therapeutics Inc., Monopar Therapeutics Inc.
Chemoradiotherapy (CRT)-induced severe oral mucositis (SOM) in patients with oropharyngeal cancer (OPC) Mucositis oral severa (MOS) inducida por quimioradioterapia (QRT) en pacientes con cáncer orofaríngeo (COF), Severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
VOICE, NCT04648020: Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Terminated
2b
190
Europe, US
Clonidine HCl Mucoadhesive Buccal Tablet, Validive®, Placebo Mucoadhesive Buccal Tablet
Monopar Therapeutics
Chemoradiotherapy-Induced Severe Oral Mucositis
05/23
05/23

Download Options